Vu Le

Array ( [id] => 15038629 [patent_doc_number] => 20190330319 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => STABLE AQUEOUS ANTI-C5 ANTIBODY COMPOSITION [patent_app_type] => utility [patent_app_number] => 16/470047 [patent_app_country] => US [patent_app_date] => 2017-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11064 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16470047 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11969865 [patent_doc_number] => 20170274019 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-28 [patent_title] => 'RETINAL GANGLION CELLS AND PROGENITORS THEREOF' [patent_app_type] => utility [patent_app_number] => 15/508533 [patent_app_country] => US [patent_app_date] => 2015-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 31857 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15508533 [rel_patent_id] =>[rel_patent_doc_number] =>)